IP Verse

Methods For The Identification, Evaluation And Treatment Of Patients Having Multiple Myeloma - EP3370729

PATENT ANALYSIS

Patent Details

Grant Date
Sep 27, 2023
Company
CELGENE CORPORATION
Oppositions

TEVA PHARMACEUTICAL INDUSTRIES LTD.

More patents of Celgene Corporation

EP3370729

EP2651400

EP3880802

Want to monitor this patent?

Feel free to send us a message here and we will get back to you